Growth Perspectives: Key Highlights from DCAT 2024
Frost & Sullivan
APRIL 3, 2024
Adare Pharma also expanded its European capabilities to facilitate the diversification of oral dosage expertise with a new high-shear mixer granulator designed for easy cleaning, reducing changeover times, water, and energy usage. A vital requirement is to successfully scale the formulation from clinical to commercial manufacturing quickly.
Let's personalize your content